D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
3301
PUT
Charles Schwab
SCHW
$182B
| $1.21M | ﹤0.01% |
16,600
+5,900
| +55% | +$421K |
|
|
RETA
3302
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.21M | ﹤0.01% |
+12,000
| New | +$1.41M |
|
3303
PUT
NeoGenomics
NEO
$1.99B
| $1.21M | ﹤0.01% |
25,000
| – | – |
|
|
GLAQ
3304
DELISTED
Globis Acquisition Corp. common stock
GLAQ
| $1.21M | ﹤0.01% |
120,034
+11,271
| +10% | +$113K |
|
3305
PUT
Kimberly-Clark
KMB
$37.6B
| $1.21M | ﹤0.01% |
9,100
-4,400
| -33% | -$598K |
|
|
FAAS
3306
DELISTED
DigiAsia
FAAS
| $1.2M | ﹤0.01% |
+120,416
| New | +$1.19M |
|
3307
CALL
Kaiser Aluminum
KALU
$2.48B
| $1.2M | ﹤0.01% |
11,000
| – | – |
|
3308
Pricesmart
PSMT
$5.94B
| $1.2M | ﹤0.01% |
15,455
+12,546
| +431% | +$1.06M |
|
|
CDMO
3309
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.2M | ﹤0.01% |
55,521
+28,200
| +103% | +$681K |
|
|
CTRA
3310
PUT
DELISTED
Coterra Energy
CTRA
| $1.2M | ﹤0.01% |
+54,937
| New | +$942K |
|
3311
Associated Banc-Corp
ASB
$5.8B
| $1.19M | ﹤0.01% |
55,747
+30,744
| +123% | +$625K |
|
3312
CALL
Enbridge
ENB
$120B
| $1.19M | ﹤0.01% |
30,000
| – | – |
|
|
TWCBU
3313
DELISTED
Bilander Acquisition Corp. Unit
TWCBU
| $1.19M | ﹤0.01% |
+119,603
| New | +$1.18M |
|
3314
Carlisle Companies
CSL
$13.5B
| $1.19M | ﹤0.01% |
5,999
-6,376
| -52% | -$1.29M |
|
3315
CALL
Northern Oil and Gas
NOG
$2.29B
| $1.19M | ﹤0.01% |
55,700
| – | – |
|
|
RAD
3316
DELISTED
Rite Aid Corporation
RAD
| $1.19M | ﹤0.01% |
83,946
+61,749
| +278% | +$972K |
|
3317
Honda
HMC
$39.8B
| $1.19M | ﹤0.01% |
38,842
+9,150
| +31% | +$288K |
|
3318
PUT
Yeti Holdings
YETI
$3.87B
| $1.19M | ﹤0.01% |
+13,900
| New | +$1.35M |
|
|
ELIQ
3319
DELISTED
Electriq Power Holdings, Inc.
ELIQ
| $1.19M | ﹤0.01% |
120,459
| – | – |
|
3320
Digital Realty Trust
DLR
$69.6B
| $1.19M | ﹤0.01% |
8,207
+6,612
| +415% | +$1.04M |
|
3321
HUTCHMED
HCM
$1.96B
| $1.19M | ﹤0.01% |
32,364
+25,202
| +352% | +$991K |
|
|
VMEO
3322
DELISTED
Vimeo
VMEO
| $1.18M | ﹤0.01% |
40,227
+13,842
| +52% | +$546K |
|
|
SEI
3323
Solaris Energy Infrastructure
SEI
$2.66B
| $1.18M | ﹤0.01% |
141,608
+101,951
| +257% | +$827K |
|
3324
CALL
Realty Income
O
$61.1B
| $1.18M | ﹤0.01% |
18,782
+8,462
| +82% | +$571K |
|
3325
Barings BDC
BBDC
$869M
| $1.18M | ﹤0.01% |
106,792
-26,024
| -20% | -$281K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.